drugset / Trial / NCT01656720
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of NRL001 in the treatment of faecal incontinence, compared against placebo
Timeline
- Start
- 2012-02
- Primary completion
- 2013-12
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 1R, 2S-methoxamine hydrochloride | Unknown | 5 mg | — |
| Comparator | 1R, 2S-methoxamine hydrochloride | Unknown | 7.5 mg | — |
| Comparator | 1R, 2S-methoxamine hydrochloride | Unknown | 10 mg | — |
Indications
No indication recorded.